Develop A Regenerative Technology To Potentially Cure Type 1 Diabetes Without The Need For Chronic Immuno-suppression

Name: Develop A Regenerative Technology To Potentially Cure Type 1 Diabetes Without The Need For Chronic Immuno-suppression
Start: 2023-01-20
End: 2024-12-31
Location: KADIMASTEM LTD.

KADIMASTEM LTD. Israel has Released a tender for Develop A Regenerative Technology To Potentially Cure Type 1 Diabetes Without The Need For Chronic Immuno-suppression in . The tender was released on Jan 01, 1970.

Country - Israel

Summary - Develop A Regenerative Technology To Potentially Cure Type 1 Diabetes Without The Need For Chronic Immuno-suppression

Deadline - Dec 31, 2024

MT reference number - 10839344

Product classification -

Organization Details:

Address - Israel

Contact details - 565656565

Tender notice no. - 76454545

MT Ref Id - 10839344

Document Type - Tender Notices

Notice Details and Documents:

Description - Scope ; Kadimastem Ltd. (Ness Ziona, Israel), and iTolerance (Miami, FL) who will develop a regenerative technology to potentially cure type 1 diabetes without the need for chronic immuno-suppression. Medical Tenders is not only confined to tenders but we also upload crucial information, from future prospects to past market records.

Mt Ref Id - 10839344

Deadline - Dec 31, 2024

View more tenders for

Israel Tenders

Most Searched